More than half of FDA trials recruit from lower middle income countries, but country enrollment is rarely reported
An analysis of 144 pivotal trials for U.S. Food and Drug Administration (FDA)-approved medications in cancer, cardiovascular disease, and neurology has found that more than half of the studies recruit patients from low- and ...
Nov 22, 2022
0
4